180 related articles for article (PubMed ID: 23551874)
1. INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.
Fumagalli G; Fabiani F; Forte S; Napolitano M; Marinelli P; Palange P; Pentassuglia A; Carlone S; Sanguinetti CM
Multidiscip Respir Med; 2013 Apr; 8(1):28. PubMed ID: 23551874
[TBL] [Abstract][Full Text] [Related]
2. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy.
Fumagalli G; Fabiani F; Forte S; Napolitano M; Balzano G; Bonini M; De Simone G; Fuschillo S; Pentassuglia A; Pasqua F; Alimonti P; Carlone S; Sanguinetti CM
Multidiscip Respir Med; 2015; 10(1):4. PubMed ID: 25973198
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of different comorbidities in COPD patients by gender and GOLD stage.
Dal Negro RW; Bonadiman L; Turco P
Multidiscip Respir Med; 2015; 10(1):24. PubMed ID: 26246895
[TBL] [Abstract][Full Text] [Related]
4. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
5. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
[No Abstract] [Full Text] [Related]
6. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbidities in COPD clinical control criteria. The CLAVE study.
Almagro P; Soler-Cataluña JJ; Huerta A; González-Segura D; Cosío BG;
BMC Pulm Med; 2024 Jan; 24(1):6. PubMed ID: 38166965
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.
Rubinsztajn R; Przybyłowski T; Grabicki M; Karwat K; Maskey-Warzęchowska M; Batura-Gabryel H; Chazan R
Adv Clin Exp Med; 2019 Mar; 28(3):319-324. PubMed ID: 30943332
[TBL] [Abstract][Full Text] [Related]
9. Overuse of long-acting β
Brunton SA; Hogarth DK
Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
[TBL] [Abstract][Full Text] [Related]
10. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients referred to Canary Island pneumology outpatient services for chronic obstructive pulmonary disease: the EPOCan study.
Figueira-Gonçalves JM; Hernández-Pérez JM; Cabrera-López C; Wangüemert-Pérez AL; García-Talavera I; Ramallo-Fariña Y; Ramos-Izquierdo C; González-García LM; Guanche-Dorta S
BMC Res Notes; 2022 Feb; 15(1):36. PubMed ID: 35144675
[TBL] [Abstract][Full Text] [Related]
12. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
[TBL] [Abstract][Full Text] [Related]
13. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
14. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
Zhang J; Lin XF; Bai CX
Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
[TBL] [Abstract][Full Text] [Related]
16. Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil.
Zucchi JW; Franco EAT; Schreck T; Castro E Silva MH; Migliorini SRDS; Garcia T; Mota GAF; de Morais BEB; Machado LHS; Batista ANR; de Paiva SAR; de Godoy I; Tanni SE
Int J Chron Obstruct Pulmon Dis; 2020; 15():2847-2856. PubMed ID: 33192058
[TBL] [Abstract][Full Text] [Related]
17. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
[TBL] [Abstract][Full Text] [Related]
18. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
19. Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.
Ge H; Liu X; Gu W; Feng X; Zhang F; Han F; Qian Y; Jin X; Gao B; Yu L; Bao H; Zhou M; Li S; Jie Z; Wang J; Chen Z; Hang J; Zhang J; Zhu H
J Inflamm Res; 2021; 14():3335-3348. PubMed ID: 34290518
[TBL] [Abstract][Full Text] [Related]
20. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
Alexopoulos EC; Malli F; Mitsiki E; Bania EG; Varounis C; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2015; 10():2665-74. PubMed ID: 26715845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
